IQV
NYSEIQVIA HOLDINGS INC.
Health Care, Life Sciences Tools & Services
close 7 Aug 2026
52-week change
market cap
52-week range
Expected price
Expected price
$236.69 – $289.28
Current price
$238.70
Signal
Appears fairly valued
A historical-multiple reference, never a fair-value claim. The band uses only data public at each date and ends at the latest month — no forward estimates.
Current multiples
Context
Forward — analyst consensus
Street view
5-year history
Dashed line: average of month-end values
P/E (TTM)
P/S (TTM)
P/B
FCF yield (TTM)
period to 31 Mar 2026, filed 5 May 2026, close 7 Aug 2026
Discounted cash flow
Ten projected years plus a perpetuity, prefilled from filings — a model to argue with, never a fair-value claim.
Free cash flow, last ten years and TTM
5Y CAGR +8.84%10Y CAGR +17.82%
Assumptions
As filed — not assumptions
Result
Projected FCF, years 1–10
Hover for PV and growth
Projection detail
Override growth for any year; blank years use the uniform rate
| Year | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | Terminal |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Growth, % | 2.5 | ||||||||||
| FCF | $2.30B | $2.51B | $2.73B | $2.97B | $3.23B | $3.52B | $3.83B | $4.17B | $4.54B | $4.94B | $91.99B |
| PV | $2.13B | $2.15B | $2.17B | $2.18B | $2.20B | $2.22B | $2.23B | $2.25B | $2.27B | $2.29B | $42.61B |
period to 31 Mar 2026, filed 5 May 2026, close 7 Aug 2026